Ashraf, SadafBell, SamuelO'Leary, CaitrionaCanning, PaulMicu, IleanaFernandez, Jose AO'Hare, MichaelBarabas, PeterMcCauley, HannahBrazil, Derek PStitt, Alan WMcGeown, J GrahamCurtis, Tim M2019-04-052019-04-052019-03-21Ashraf, S, Bell, S, O'Leary, C, Canning, P, Micu, I, Fernandez, J A, O'Hare, M, Barabas, P, McCauley, H, Brazil, D P, Stitt, A W, McGeown, J G & Curtis, T M 2019, 'CAMKII as a therapeutic target for growth factor-induced retinal and choroidal neovascularisation', JCI Insight, vol. 4, no. 6, e122442. https://doi.org/10.1172/jci.insight.1224422379-3708Mendeley: 70f074c3-6461-34c2-ac7e-3978410b9eeahttp://hdl.handle.net/2164/12142This study was supported by grants from the British Heart Foundation (PG/11/99/29207 and PG/11/94/29169), Fight for Sight, UK (1387/88), Health & Social Care R&D Division, Northern Ireland (STL/4748/13) and the Medical Research Council (MC_PC_15026). We would like to thank Gordon Revolta for excellent assistance with colony management and genotyping.1783573engSDG 3 - Good Health and Well-beingPROTEIN-KINASE-IIPROLIFERATIVE DIABETIC-RETINOPATHYOXYGEN-INDUCED RETINOPATHYDELTA ISOFORMANGIOGENESISVEGFACTIVATIONMOUSEINHIBITIONINSULINR MedicineGeneral MedicineMedical Research Council (MRC)MC_PC_15026British Heart FoundationPG/11/99/29207PG/11/94/29169RJournal article10.1172/jci.insight.122442http://www.mendeley.com/research/camkii-therapeutic-target-growth-factorinduced-retinal-choroidal-neovascularisationhttp://www.scopus.com/inward/record.url?scp=85070659509&partnerID=8YFLogxK46